Blood and blood forming organs

Filters
Category
Release Form
Primary Package
Status
Dossier Type
Search

Blood and blood forming organs

Acetylsalicylic acid

Blood and blood forming organs

Film-coated Tablets

Film-coated Tablets

75mg, 150mg

Blister, OTC, CTD
More Less

Clopidogrel

Blood and blood forming organs

Film-coated Tablets

Film-coated Tablets

75mg

Blister, Rx, CTD
More Less

Enoxaparin

Blood and blood forming organs

Solution for Injection

Solution for Injection

2000 anti-Xa IU: 0.2mL
4000 anti-Xa IU: 0.4mL
6000 anti-Xa IU: 0.6mL
8000 anti-Xa IU: 0.8mL

PFS, Rx, CTD
Solution for Injection

30 000 anti-Xa IU: 3mL

Vial, Rx, CTD
More Less

Ferric carboxymaltose

Blood and blood forming organs

Solution for Injection

Solution for Injection

50mg iron/mL: 2mL, 10mL, 20mL

Vial, Rx, EU CTD
More Less

Fondaparinux

Blood and blood forming organs

Solution for Injection

Solution for Injection

2.5mg/0.5mL: 0.5mL

PFS, Rx, CTD
More Less

Tranexamic acid

Blood and blood forming organs

Film-coated Tablets Solution for Injection

Film-coated Tablets

500mg

Blister, Rx, CTD
Solution for Injection

100mg/mL: 5mL, 10mL

Ampoule, Rx, EU CTD
More Less

Farmak International offers medications developed to treat conditions related to issues with blood and blood-forming organs. Being a thromboprophylaxis supplier, we are mostly focused on thrombosis prevention. Additionally, we offer products for bleeding management.

Anticoagulation & Hemostasis Product Portfolio

As a blood modifier and cardiovascular medications distributor, Farmak International offers a comprehensive coagulation and hemostasis product portfolio. We develop and produce solutions that can be split into the following categories:

  • Low molecular weight heparins. These blood thinners efficiently prevent and treat blood clots in patients suffering from DVT, PE, angina, and heart attacks. Also, they are prescribed to immobile patients after surgeries. Being a legal LMWH pharmaceutical supplier, we deliver Enoxaparin. Regulatory bodies mandate that Enoxaparin distributors meet strict requirements for this biologically derived sterile injectable. We ensure the quality of our products with advanced good manufacturing practices.
  • Factor Xa inhibitors. These blood thinners block Factor Xa, an enzyme crucial for the blood-clotting process. We offer thrombosis prevention medications belonging to this class, such as Enoxaparin and Fondaparinux.
  • Antiplatelet agents. This group includes aspirin and P2Y12 inhibitors, which prevent blood cells (platelets) from sticking together and forming clots. As an aspirin antiplatelet distributor, we produce and market Acetylsalicylic acid and Clopidogrel.
  • Antifibrinolytic agents. These bleeding control drugs reduce or prevent severe bleeding by stopping the body from breaking down blood clots. Tranexamic acid is a typical product in the class.

In addition to procoagulants and VTE prevention medications, we offer Ferric carboxymaltose to treat bleeding-induced anemia in patients who cannot benefit from oral iron for any reason. It is also used to improve exercise ability in adults with chronic heart failure.

Clinical Applications in Thrombosis & Hemostasis

The global thrombosis and hemostasis market is highly dependent on active ingredients, making institutional anticoagulation supply vulnerable to disruptions. Farmak International successfully contributes to preventing critical shortages that can affect patient care, as a Factor Xa inhibitors, antifibrinolytic, and antiplatelet drugs distributor.

Our products are used in healthcare for diagnosing, treating, or preventing disease in patients. We specify the medical indications, correct dosages, and methods of administration for specific conditions, including:

  • Venous thromboembolism (VTE) prevention and treatment. This serious medical condition is connected with forming a blood clot in a vein. It develops when blood flows slowly and becomes prone to clotting. As a DVT treatment drugs supplier, we offer anticoagulants to prevent and treat this condition.
  • Acute coronary syndrome (ACS) management. Blood flow to the heart muscle can be suddenly reduced due to a blood clot caused by cholesterol plaque in a coronary artery. To restore blood flow to the heart, blood thinners or clot-busters are used.
  • Cardiovascular event prevention (secondary prevention). Medical therapies protecting heart health also involve antiplatelets and anticoagulants to prevent blood clots from forming.
  • Perioperative bleeding control. During complex surgeries, doctors rely on hemostatic agents and pharmaceutical interventions to control severe bleeding. To stop blood loss before, during, and after a surgical procedure, antifibrinolytics are used. Being a Tranexamic acid supplier, we offer exactly this widely prescribed and generally preferred option.

Our medications can also be used for post-surgical thromboprophylaxis and included in hospital anticoagulation protocols.

Product Specifications & Administration Options

To ensure accurate dosing, reduce waste, and enable safe, convenient administration, injectable anticoagulant suppliers typically package medication in prefilled syringes or vials. Vials are mostly used for flexible adjustments by physicians, while prefilled syringes are convenient to be used by patients from home without the risk of dosing errors. In our CTD-ready portfolio, there are also oral antiplatelet and hemostatic agents designed in film-coated tablets with multiple dosage strengths for weight-based dosing. 

Any hospital anticoagulation options from the above list are a ready-to-use presentation for hospital convenience, being accurately pre-measured and labeled. There is no need for blending or dilution, which enhances pharmacy workflow. We strictly adhere to storage requirements. Our storage capacity is properly designed and equipped to remove environmental factors that can cause chemical degradation and physical breakdown of medications.

Quality Assurance & Safety Standards

To ensure high quality and safety of our products, we hold EU GMP certifications that prove our manufacturing facilities in Ukraine and Spain consistently meet the strictest hygiene and safety standards. As an acetylsalicylic acid, clopidogrel, enoxaparin, ferric carboxymaltose, and fondaparinux supplier in Europe, we accurately document the supply chain and test batches.

To achieve pharmacopoeia compliance for anti-Xa activity testing, we ensure that anticoagulant drugs meet globally standardised quality control and potency specifications. As a generic drug manufacturer, we develop complete regulatory dossiers (CTD, EU CTD) to sell our products to institutional distributors or healthcare procurement organisations, who will deliver them to B2B customers, such as anticoagulants supplier hospitals or directly to hospital networks. When needed, we are ready to render support for hospital anticoagulation protocols.

Institutional Supply & Partnership

We provide reliable supply for hospital anticoagulation programs and offer flexible packaging options. Whatever is preferred by our partners, whether prefilled syringe anticoagulants, vials, or film-coated tablets, we are ready to deliver our medications to Europe, the MENA region, and Central Asia.

We provide documents for tender submissions and technical support, if needed. Inclusion in institutional formularies is critical for any drug manufacturer. To position our drugs as the standard of care and increase sales volumes, we always offer competitive pricing.